Detection of homing-in of stem cells labeled with technetium-99m hexamethylpropyleneamine oxime in infarcted myocardium after intracoronary injection.
Bone marrow stem cells having myogenic potential are promising candidates for various cell-based therapies for myocardial disease. We present here images showing homing of technetium-99m (Tc-99m) hexamethylpropyleneamine oxime (HMPAO) labeled stem cells in the infarcted myocardium from a pilot study conducted to radio-label part of the stem cells in patients enrolled in a stem cell clinical trial for recent myocardial infarction.
Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Chetan D
CD
Patel
Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Snehlata
S
Agarwal
Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
Sandeep
S
Seth
Stem Cell Facility, All India Institute of Medical Sciences, New Delhi, India.
Sujata
S
Mohanty
Stem Cell Facility, All India Institute of Medical Sciences, New Delhi, India.
Himesh
H
Aggarwal
Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
Namit
N
Gupta
Bone marrow mononuclear cells; myocardium; stem cell; technetium-99m hexamethylpropyleneamine oxime